These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33692977)

  • 1. Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders.
    Jansen ME; Klein AW; Buitenhuis EC; Rodenburg W; Cornel MC
    Front Pediatr; 2021; 9():635353. PubMed ID: 33692977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective.
    van Dijk T; Kater A; Jansen M; Dondorp WJ; Blom M; Kemp S; Langeveld M; Cornel MC; van der Pal SM; Henneman L
    Front Pediatr; 2021; 9():706394. PubMed ID: 34692604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policy Making in Newborn Screening Needs a Structured and Transparent Approach.
    Jansen ME; Lister KJ; van Kranen HJ; Cornel MC
    Front Public Health; 2017; 5():53. PubMed ID: 28377917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn bloodspot screening policy framework for Australia.
    O'Leary P; Maxwell S
    Australas Med J; 2015; 8(9):292-8. PubMed ID: 26464586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide.
    Cornel MC; Rigter T; Jansen ME; Henneman L
    J Community Genet; 2021 Apr; 12(2):257-265. PubMed ID: 33074550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system.
    Andrews SM; Porter KA; Bailey DB; Peay HL
    BMC Pediatr; 2022 Feb; 22(1):90. PubMed ID: 35151296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parents' views on accepting, declining, and expanding newborn bloodspot screening.
    van der Pal SM; Wins S; Klapwijk JE; van Dijk T; Kater-Kuipers A; van der Ploeg CPB; Jans SMPJ; Kemp S; Verschoof-Puite RK; van den Bosch LJM; Henneman L
    PLoS One; 2022; 17(8):e0272585. PubMed ID: 35980961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inborn Errors of Metabolism That Cause Sudden Infant Death: A Systematic Review with Implications for Population Neonatal Screening Programmes.
    van Rijt WJ; Koolhaas GD; Bekhof J; Heiner Fokkema MR; de Koning TJ; Visser G; Schielen PC; van Spronsen FJ; Derks TG
    Neonatology; 2016; 109(4):297-302. PubMed ID: 26907928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of pregnant women's knowledge and attitudes about newborn bloodspot screening.
    Fitzgerald C; Heery E; Conneally N; Linnane B; George S; Fitzpatrick P
    Midwifery; 2017 Feb; 45():21-27. PubMed ID: 27978478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Implementation of Newborn Screening for Hemoglobin Disorders in the Philippines.
    Padilla CD; Therrell BL; Alcausin MMLB; de Castro RC; Gepte MBP; Reyes MEL; Jomento CM; Suarez RCN; Maceda EBG; Abarquez CG; Posecion JEWC; Andal AP; Elizaga ALG; Halili-Mendoza BC; Otayza MPVK; Hoppe CC
    Int J Neonatal Screen; 2021 Jun; 7(2):. PubMed ID: 34204320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe.
    Barben J; Castellani C; Dankert-Roelse J; Gartner S; Kashirskaya N; Linnane B; Mayell S; Munck A; Sands D; Sommerburg O; Pybus S; Winters V; Southern KW
    J Cyst Fibros; 2017 Mar; 16(2):207-213. PubMed ID: 28043799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010.
    Loeber JG; Platis D; Zetterström RH; Almashanu S; Boemer F; Bonham JR; Borde P; Brincat I; Cheillan D; Dekkers E; Dimitrov D; Fingerhut R; Franzson L; Groselj U; Hougaard D; Knapkova M; Kocova M; Kotori V; Kozich V; Kremezna A; Kurkijärvi R; La Marca G; Mikelsaar R; Milenkovic T; Mitkin V; Moldovanu F; Ceglarek U; O'Grady L; Oltarzewski M; Pettersen RD; Ramadza D; Salimbayeva D; Samardzic M; Shamsiddinova M; Songailiené J; Szatmari I; Tabatadze N; Tezel B; Toromanovic A; Tovmasyan I; Usurelu N; Vevere P; Vilarinho L; Vogazianos M; Yahyaoui R; Zeyda M; Schielen PCJI
    Int J Neonatal Screen; 2021 Mar; 7(1):. PubMed ID: 33808002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice.
    Lombardo S; Seedat F; Elliman D; Marshall J
    Lancet Reg Health Eur; 2023 Oct; 33():100714. PubMed ID: 37954001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening in Latin America at the beginning of the 21st century.
    Borrajo GJ
    J Inherit Metab Dis; 2007 Aug; 30(4):466-81. PubMed ID: 17701285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded newborn bloodspot screening: developed country examples and what can be done in Turkey.
    Fidan Ç; Örün H; Alper AB; Ünver ÇN; Şahin ÖC; Uğurlu Z; Akdur R; Taruscio D
    Intractable Rare Dis Res; 2022 May; 11(2):63-69. PubMed ID: 35702584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).
    Therrell BL; Padilla CD; Borrajo GJC; Khneisser I; Schielen PCJI; Knight-Madden J; Malherbe HL; Kase M
    Int J Neonatal Screen; 2024 May; 10(2):. PubMed ID: 38920845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol.
    Nicholls SG; Tessier L; Etchegary H; Brehaut JC; Potter BK; Hayeems RZ; Chakraborty P; Marcadier J; Milburn J; Pullman D; Turner L; Wilson BJ
    BMJ Open; 2014 Nov; 4(11):e006782. PubMed ID: 25421341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Strategies to Decrease False Positive Results in Newborn Screening.
    Malvagia S; Forni G; Ombrone D; la Marca G
    Int J Neonatal Screen; 2020 Nov; 6(4):. PubMed ID: 33147868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.